EW Edwards Lifesciences beats by $0.07, beats on revenue Edwards Lifesciences (NYSE:EW): Q3 EPS of $0.80 beats by $0.07. Revenue of $607.4M (+22.6% Y/Y) beats by $61.08M. Shares +5.71% AH.